These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9621157)

  • 1. Fixed drug eruption due to metronidazole and tinidazole without cross-sensitivity to secnidazole.
    Thami GP; Kanwar AJ
    Dermatology; 1998; 196(3):368. PubMed ID: 9621157
    [No Abstract]   [Full Text] [Related]  

  • 2. Recurrent fixed drug eruption due to metronidazole elicited by patch test with tinidazole.
    Prieto A; De Barrio M; Infante S; Torres A; Rubio M; Olalde S
    Contact Dermatitis; 2005 Sep; 53(3):169-70. PubMed ID: 16128758
    [No Abstract]   [Full Text] [Related]  

  • 3. Fixed drug eruption with ornidazole having cross-sensitivity to secnidazole but not to other nitro-imidazole compounds: a case report.
    Sanmukhani J; Shah V; Baxi S; Tripathi C
    Br J Clin Pharmacol; 2010 Jun; 69(6):703-4. PubMed ID: 20565463
    [No Abstract]   [Full Text] [Related]  

  • 4. Fixed drug eruption with albendazole and it's cross-sensitivity with metronidazole--a case report.
    Mahboob A; Haroon TS
    J Pak Med Assoc; 1998 Oct; 48(10):316-7. PubMed ID: 10087757
    [No Abstract]   [Full Text] [Related]  

  • 5. Fixed drug eruption and cross-reactivity between tinidazole and metronidazole.
    Mishra D; Mobashir M; Zaheer MS
    Int J Dermatol; 1990 Dec; 29(10):740. PubMed ID: 2148563
    [No Abstract]   [Full Text] [Related]  

  • 6. Fixed drug eruption due to tinidazole with cross-reactivity with metronidazole.
    Kanwar AJ; Sharma R; Rajagopalan M; Kaur S
    Dermatologica; 1990; 180(4):277. PubMed ID: 2141581
    [No Abstract]   [Full Text] [Related]  

  • 7. [A therapeutic trial in Giardia muris infection in the mouse with metronidazole, tinidazole, secnidazole and furazolidone].
    Cruz CC; Ferrari L; Sogayar R
    Rev Soc Bras Med Trop; 1997; 30(3):223-8. PubMed ID: 9273569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of 5-nitroimidazoles for the treatment of giardiasis: a systematic review of randomized controlled trials.
    Pasupuleti V; Escobedo AA; Deshpande A; Thota P; Roman Y; Hernandez AV
    PLoS Negl Trop Dis; 2014 Mar; 8(3):e2733. PubMed ID: 24625554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Nitroimidazole refractory giardiasis is common in Matanzas, Cuba and effectively treated by secnidazole plus high-dose mebendazole or quinacrine: a prospective observational cohort study.
    Cañete R; Noda AL; Rodríguez M; Brito K; Herrera E; Kofoed PE; Ursing J
    Clin Microbiol Infect; 2020 Aug; 26(8):1092.e1-1092.e6. PubMed ID: 31901492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trial with Secnidazole in a single dose in Venezuelan children infected by Giardia intestinalis.
    Di Prisco MC; Jiménez JC; Rodríguez N; Costa V; Villamizar J; Silvera A; Carrillo M; Lira C; Zerpa E; López Y
    Invest Clin; 2000 Sep; 41(3):179-88. PubMed ID: 11029834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fixed-drug eruption due to metronidazole with positive topical provocation.
    Gastaminza G; Anda M; Audicana MT; Fernandez E; Muñoz D
    Contact Dermatitis; 2001 Jan; 44(1):36. PubMed ID: 11156011
    [No Abstract]   [Full Text] [Related]  

  • 12. Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) associated with pristinamycin, secnidazole, and nefopam, with a review of the literature.
    Nespoulous L; Matei I; Charissoux A; Bédane C; Assikar S
    Contact Dermatitis; 2018 Dec; 79(6):378-380. PubMed ID: 30062790
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tinidazole, its use in the treatment of recurrent giardiasis in childhood. Preliminary report].
    Castañeda Guillot C; Sagaro González E; Blanco Rabassa E
    Rev Cubana Med Trop; 1984; 36(3):368-75. PubMed ID: 6399945
    [No Abstract]   [Full Text] [Related]  

  • 14. A randomized trial comparing mebendazole and secnidazole for the treatment of giardiasis.
    Escobedo AA; Cañete R; Gonzalez ME; Pareja A; Cimerman S; Almirall P
    Ann Trop Med Parasitol; 2003 Jul; 97(5):499-504. PubMed ID: 12930613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secnidazole response in amoebiasis and giardiasis.
    Qureshi H; Baqai R; Mehdi I; Ahmed W
    East Mediterr Health J; 1999 Mar; 5(2):389-90. PubMed ID: 10793818
    [No Abstract]   [Full Text] [Related]  

  • 16. Tinidazole (Tindamax) - a new anti-protozoal drug.
    Med Lett Drugs Ther; 2004 Aug; 46(1190):70-2. PubMed ID: 15375353
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of various drugs for treatment of giardiasis. A comparative study.
    Levi GC; de Avila CA; Amato Neto V
    Am J Trop Med Hyg; 1977 May; 26(3):564-5. PubMed ID: 869108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bullous fixed drug eruption induced by intravaginal metronidazole ovules, with positive topical provocation test findings.
    Hermida MD; Consalvo L; Lapadula MM; Della Giovanna P; Cabrera HN
    Arch Dermatol; 2011 Feb; 147(2):250-1. PubMed ID: 21339462
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative efficacy of drugs for treating giardiasis: a systematic update of the literature and network meta-analysis of randomized clinical trials.
    Ordóñez-Mena JM; McCarthy ND; Fanshawe TR
    J Antimicrob Chemother; 2018 Mar; 73(3):596-606. PubMed ID: 29186570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fixed drug eruption due to cross reaction between two azoles used for different indications.
    Bansal A; Kumari R; Ramam M
    Indian J Dermatol Venereol Leprol; 2008; 74(1):81. PubMed ID: 18193506
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.